Figure 1From: Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cellsThe cellular origins of pathogenic 'activated' fibroblasts in scleroderma. Scleroderma (SSc) fibrosis is characterised by the excessive accumulation of extracellular matrix (ECM) proteins, including type I and type III collagen, by 'activated fibroblasts' or myofibroblasts and leads to the development of pathological scaring and loss of organ function. These cells arise from a differentiation of resident and recruited circulating progenitor cells and collectively are likely to contribute the myofibroblast population. Myofibroblasts have been shown to arise from a number of cellular sources through the differentiation and activation of tissue-resident cells: epithelial to mesenchymal transition; endothelial to mesenchymal transition; fibroblast to myofibroblast transition; pericyte to mesenchymal transition; smooth muscle cell differentiation. In addition the recruitment and differentiation of circulating bone marrow-derived cells (BMDC) and fibrocytes can contribute to the myofibroblast population. SSc fibroblasts also promote a pro-fibrotic microenvironment, secreting growth factors, chemokines and cytokines that can in turn act on resident and infiltrating cells in an autocrine and paracrine manner to expand the reservoir of pro-fibrotic fibroblasts present in SSc fibrotic lesions.Back to article page